Related references
Note: Only part of the references are listed.Iduronate-2-sulfatase fused with anti-hTfR antibody, pabinafusp alfa, for MPS-II: A phase 2 trial in Brazil
Roberto Giugliani et al.
MOLECULAR THERAPY (2021)
Integral Membrane Protein 2A Is a Negative Regulator of Canonical and Non-Canonical Hedgehog Signalling
Cintli C. Morales-Alcala et al.
CELLS (2021)
Blood-Brain Barrier and Delivery of Protein and Gene Therapeutics to Brain
William M. Pardridge
FRONTIERS IN AGING NEUROSCIENCE (2020)
An Interspecies Molecular and Functional Study of Organic Cation Transporters at the Blood-Brain Barrier: From Rodents to Humans
Catarina Chaves et al.
PHARMACEUTICS (2020)
Non-Human Primate Blood-Brain Barrier and In Vitro Brain Endothelium: From Transcriptome to the Establishment of a New Model
Catarina Chaves et al.
PHARMACEUTICS (2020)
Functionalization of amyloid fibrils via the Bri2 BRICHOS domain
Henrik Biverstal et al.
SCIENTIFIC REPORTS (2020)
Large-Scale Quantitative Comparison of Plasma Transmembrane Proteins between Two Human Blood-Brain Barrier Model Cell Lines, hCMEC/D3 and HBMEC/ciβ
Takeshi Masuda et al.
MOLECULAR PHARMACEUTICS (2019)
Targeting the transferrin receptor for brain drug delivery
Kasper Bendix Johnsen et al.
PROGRESS IN NEUROBIOLOGY (2019)
Single Cell Analysis of Endothelial Cells Identified Organ-Specific Molecular Signatures and Heart-Specific Cell Populations and Molecular Features
Wei Feng et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2019)
Endosomal trafficking regulates receptor-mediated transcytosis of antibodies across the blood brain barrier
Arsalan S. Haqqani et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2018)
Antibody pharmacokinetics in rat brain determined using microdialysis
Hsueh-Yuan Chang et al.
MABS (2018)
A Blood-Brain-Barrier-Penetrating Anti-human Transferrin Receptor Antibody Fusion Protein for Neuronopathic Mucopolysaccharidosis II
Hiroyuki Sonoda et al.
MOLECULAR THERAPY (2018)
Brain Cell Type Specific Gene Expression and Co-expression Network Architectures
Andrew T. McKenzie et al.
SCIENTIFIC REPORTS (2018)
Passive Immunotherapies for Central Nervous System Disorders: Current Delivery Challenges and New Approaches
Niyanta N. Kumar et al.
BIOCONJUGATE CHEMISTRY (2018)
Emerging Technologies for Delivery of Biotherapeutics and Gene Therapy Across the Blood-Brain Barrier
Danica B. Stanimirovic et al.
BIODRUGS (2018)
Use of LDL receptor-targeting peptide vectors for in vitro and in vivo cargo transport across the blood-brain barrier
Yves Molino et al.
FASEB JOURNAL (2017)
The GPRC6A receptor displays constitutive internalization and sorting to the slow recycling pathway
Stine Engesgaard Jacobsen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
In vitro models of the blood-brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use
Hans C. Helms et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2016)
From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery
William A. Banks
NATURE REVIEWS DRUG DISCOVERY (2016)
Discovery of Novel Blood-Brain Barrier Targets to Enhance Brain Uptake of Therapeutic Antibodies
Y. Joy Yu Zuchero et al.
NEURON (2016)
Purification and Characterization of Progenitor and Mature Human Astrocytes Reveals Transcriptional and Functional Differences with Mouse
Ye Zhang et al.
NEURON (2016)
The integral membrane protein ITM2A, a transcriptional target of PKA-CREB, regulates autophagic flux via interaction with the vacuolar ATPase
Sim Namkoong et al.
AUTOPHAGY (2015)
Blood-brain barrier models: in vitro to in vivo translation in preclinical development of CNS-targeting biotherapeutics
Danica B. Stanimirovic et al.
EXPERT OPINION ON DRUG DISCOVERY (2015)
Mental retardation-related protease, motopsin (prss12), binds to the BRICHOS domain of the integral membrane protein 2a
Shinichi Mitsui et al.
CELL BIOLOGY INTERNATIONAL (2014)
Itm2a Expression in the Developing Mouse First Lower Molar, and the Subcellular Localization of Itm2a in Mouse Dental Epithelial Cells
Makiko Kihara et al.
PLOS ONE (2014)
G-Protein coupled receptor 64 promotes invasiveness and metastasis in Ewing sarcomas through PGF and MMP1
Guenther H. S. Richter et al.
JOURNAL OF PATHOLOGY (2013)
Development, maintenance and disruption of the blood-brain barrier
Birgit Obermeier et al.
NATURE MEDICINE (2013)
Itm2a Is a Pax3 Target Gene, Expressed at Sites of Skeletal Muscle Formation In Vivo
Mounia Lagha et al.
PLOS ONE (2013)
Heterogeneity in the rat brain vasculature revealed by quantitative confocal analysis of endothelial barrier antigen and P-glycoprotein expression
Bruno Saubamea et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2012)
Transcriptional Profiling of Human Brain Endothelial Cells Reveals Key Properties Crucial for Predictive In Vitro Blood-Brain Barrier Models
Eduard Urich et al.
PLOS ONE (2012)
Glycemic Control and Chronic Dosing of Rhesus Monkeys with a Fusion Protein of Iduronidase and a Monoclonal Antibody Against the Human Insulin Receptor
Ruben J. Boado et al.
DRUG METABOLISM AND DISPOSITION (2012)
Ubiquitination Regulates the Internalization, Endolysosomal Sorting, and Signaling of the Erythropoietin Receptor
Gamze Betul Bulut et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Exposure Levels of Anti-LINGO-1 Li81 Antibody in the Central Nervous System and Dose-Efficacy Relationships in Rat Spinal Cord Remyelination Models after Systemic Administration
R. Blake Pepinsky et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Development of new peptide vectors for the transport of therapeutic across the blood-brain barrier
Reinhard Gabathuler
THERAPEUTIC DELIVERY (2010)
Enhanced ITM2A expression inhibits chondrogenic differentiation of mesenchymal stem cells
Stephane Boeuf et al.
DIFFERENTIATION (2009)
The epithelial membrane protein 1 is a novel tight junction protein of the blood-brain barrier
Thorsten Bangsow et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2008)
Subcellular localization of transporters along the rat blood-brain barrier and blood-cerebral-spinal fluid barrier by in vivo biotinylation
L. M. Roberts et al.
NEUROSCIENCE (2008)
Isolation, sequence identification and tissue expression distribution of three novel porcine genes - RAB14, S35A3 and ITM2A
G. Y. Liu et al.
MOLECULAR BIOLOGY REPORTS (2008)
Identification and design of peptides as a new drug delivery system for the brain
Michel Demeule et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
A functional in vitro model of rat blood-brain barrier for molecular analysis of efflux transporters
Nicolas Perriere et al.
BRAIN RESEARCH (2007)
PIN-G - A novel reporter for imaging and defining the effects of trafficking signals in membrane proteins
Lynn McKeown et al.
BMC BIOTECHNOLOGY (2006)
Puromycin-based purification of rat brain capillary endothelial cell cultures.: Effect on the expression of blood-brain barrier-specific properties
N Perrière et al.
JOURNAL OF NEUROCHEMISTRY (2005)
In vitro studies on Itm2a reveal its involvement in early stages of the chondrogenic differentiation pathway
D Van den Plas et al.
BIOLOGY OF THE CELL (2004)
Constitutive overexpression of the integral membrane protein Itm2A enhances myogenic differentiation of C2C12 cells
D Van den Plas et al.
CELL BIOLOGY INTERNATIONAL (2004)
Rat blood-brain barrier genomics. II
JY Li et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2002)
Collagenase-3 (MMP-13) and integral membrane protein 2a (Itm2a) are marker genes of chondrogenic/osteoblastic cells in bone formation:: Sequential temporal, and spatial expression of Itm2a, alkaline phosphatase, MMP-13, and osteocalcin in the mouse
JP Tuckermann et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2000)
Share Paper
